Dendritic cells as natural adjuvants

被引:20
|
作者
Citterio, S
Rescigno, M
Foti, M
Granucci, F
Aggujaro, D
Gasperi, C
Matyszak, MK
Girolomoni, G
Ricciardi-Castagnoli, P [1 ]
机构
[1] Univ Milan, CNR, Cellular & Mol Pharmacol Ctr, Dept Biotechnol & Biol Sci, I-20129 Milan, Italy
[2] IRCCS, Immunol Lab, Ist Dermopat Immacolata, Rome, Italy
来源
关键词
D O I
10.1006/meth.1999.0839
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Dendritic cells (DCs) are professional antigen presenting cells that hold the hey to the induction of T-cell responses. Therefore, the use of DCs for immunotherapy to stimulate immune responses has recently raised a great deal of interest. Many clinical trials using DCs have been initiated to stimulate immune responses against tumors or infectious agents. Several issues need to be considered before DCs can be used successfully as natural adjuvants: DCs have to be generated in sufficient numbers; they should display morphological, phenotypical, and functional properties of DCs; and they should be able to present antigens. In the present review we focus on methods for the purification of DCs from human bone marrow and peripheral blood and for the optimization of in vitro cell culture systems. Methods to generate growth factor-dependent mouse DC lines are also described. (C) 1999 Academic Press.
引用
收藏
页码:142 / 147
页数:6
相关论文
共 50 条
  • [41] Accessing natural vaccine adjuvants
    Courdavault, Vincent
    Papon, Nicolas
    [J]. NATURE CHEMICAL BIOLOGY, 2024, 20 (04) : 401 - 403
  • [42] Accessing natural vaccine adjuvants
    Vincent Courdavault
    Nicolas Papon
    [J]. Nature Chemical Biology, 2024, 20 : 401 - 403
  • [43] Natural Compounds as Promising Adjuvants in Cancer Therapy; Sensitizer of Cancer Cells, and Protector of Healthy Cells
    Ahmadi, Amirhossein
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2022, 22 (04) : 604 - 604
  • [44] Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity
    Young, JW
    Inaba, K
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01): : 7 - 11
  • [45] IL-12-engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo
    Zitvogel, L
    Couderc, B
    Mayordomo, JI
    Robbins, PD
    Lotze, MT
    Storkus, WJ
    [J]. INERLEUKIN 12: CELLULAR AND MOLECULAR IMMUNOLOGY OF AN IMPORTANT REGULATORY CYTOKINE, 1996, 795 : 284 - 293
  • [46] Impact of aluminum-containing adjuvants on IL-1 beta production by dendritic cells
    Sokolovska, A
    HogenEsch, H
    [J]. FASEB JOURNAL, 2003, 17 (07): : C200 - C200
  • [47] Despite profound effects on intestinal dendritic cells, TLR ligands do not act as oral adjuvants
    Milling, SWF
    Jenkins, C
    Singanayagam, A
    Yrlid, U
    Cerovic, V
    Klavinskis, L
    MacPherson, GG
    [J]. IMMUNOLOGY, 2005, 116 : 84 - 85
  • [48] Adjuvants LT-K63 and CpG enhance the activation of dendritic cells in neonatal mice
    Hannesdottir, S. G.
    Olafsdottir, T. A.
    Giudice, G. D.
    Jonsdottir, I.
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2008, 68 (05) : 469 - 475
  • [49] Dendritic cells activate natural killers in biliary atresia
    Andy McLarnon
    [J]. Nature Reviews Gastroenterology & Hepatology, 2011, 8 (12) : 660 - 660
  • [50] Liaison between natural killer cells and dendritic cells in human gestation
    Leno-Duran, Ester
    Munoz-Fernandez, Raquel
    Garcia Olivares, Enrique
    Tirado-Gonzalez, Irene
    [J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2014, 11 (05) : 449 - 455